Genetics of sarcoidosis
Joachim Müller-Quernheim1, Manfred Schürmann, Sylvia Hofmann
1Department of Pneumology, University Medical Center, Killianstrasse 5, Freiburg, Germany. jmq@medizin.ukl.uni-freiburg.de
Clinics in Chest Medicine
|June 10, 2008
Summary
Genetic research is advancing our understanding of sarcoidosis, a complex disease. Identifying genetic risk profiles may improve clinical translation for sarcoidosis and other inflammatory disorders.
Area of Science:
- Genetics
- Immunology
- Proteomics
Background:
- Sarcoidosis is a complex disease influenced by multiple genes and factors.
- Advances in molecular technologies like genome-wide association studies are identifying predisposing genes.
- Further research is needed to understand the role of genetic variants in sarcoidosis pathogenesis.
Purpose of the Study:
- To explore the molecular epidemiology of genetic variants in sarcoidosis.
- To assess the prognostic utility of identified genetic variants.
- To investigate granulomatous disorders using integrated genetic, immunobiological, and proteomic approaches.
Main Methods:
- Genome-wide association studies (GWAS)
- Large-scale resequencing
- Genetic, immunobiological, and proteomic analyses of granulomatous disorders
Main Results:
- Identification of predisposing genes for sarcoidosis.
- Potential for discovery of further risk loci and variants through advanced molecular technologies.
- Establishment of a foundation for defining individual genetic risk profiles.
Conclusions:
- Defining individual genetic risk profiles in sarcoidosis and other chronic inflammatory disorders is achievable.
- This approach offers a promising route for clinical translation.
- Integrated research strategies are crucial for understanding complex diseases like sarcoidosis.
Related Concept Videos
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:35Pedigree Analysis
Overview
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...